(19)
(11) EP 4 114 452 A1

(12)

(43) Date of publication:
11.01.2023 Bulletin 2023/02

(21) Application number: 21709001.8

(22) Date of filing: 03.03.2021
(51) International Patent Classification (IPC): 
A61K 39/12(2006.01)
 C07K 14/005(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 39/12; C07K 14/005; C12N 2770/20022; C12N 2770/20034; A61K 2039/53
(86) International application number:
PCT/EP2021/055401
(87) International publication number:
WO 2021/175960 (10.09.2021 Gazette 2021/36)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 03.03.2020 EP 20020092
20.05.2020 EP 20020240

(71) Applicant: Rocketvax AG
4051 Basel (CH)

(72) Inventor:
  • CHRISTEN, Matthias
    4153 Reinach (CH)

(74) Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB 
Siebertstraße 3
81675 München
81675 München (DE)

   


(54) FULLY SYNTHETIC, LONG-CHAIN NUCLEIC ACID FOR VACCINE PRODUCTION TO PROTECT AGAINST CORONAVIRUSES